Moderna Inc (MRNA)

$102.00 1.44 (1.39%)

16:00 EDT MRNA Stock Quote Delayed 30 Minutes

3 Pharma Stocks to Sell in April Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor Apr 11, 2024

Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

Volume:

Previous Close -

Market Cap 38.96B

PE Ratio -8.23

EPS -12.4

Volume (Avg. Vol.) 1.80M

Day's Range $99.90 - $103.51

52-Week Range $62.55 - $144.93

Dividend & Yield N/A (N/A)

MRNA Stock Predictions, Articles, and Moderna Inc News

From InvestorPlace
From the Web

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

By Shane Neagle, InvestorPlace Contributor Mar 28, 2024

Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.

3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise

By Matthew Farley, InvestorPlace Contributor Mar 15, 2024

Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities.

Turnaround Plays: 3 Stocks to Buy for a Major Recovery in 2024

By Joel Baglole, InvestorPlace Contributor Mar 8, 2024

While most companies that change their plans fail, investors should pay attention to these three turnaround stocks poised for recovery.

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise

By Shane Neagle, InvestorPlace Contributor Mar 7, 2024

Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.

7 F-Rated Stocks to Sell in March 2024

By Louis Navellier and the InvestorPlace Research Staff Mar 7, 2024

This market is too strong to risk holding F-rated stocks. If you're still seeing these names in your portfolio, it's time to make a move.

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

By Noah Bolton, InvestorPlace Contributor Mar 5, 2024

The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

By Viktor Zarev, InvestorPlace Contributor Mar 4, 2024

Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.

Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short

By Joel Baglole, InvestorPlace Contributor Feb 28, 2024

In recent weeks, stocks have risen and fallen dramatically based on the financial results of the companies behind them. Investor portfolios have been violently jostled by the prints, many of which surprised people on both Wall Street and Main Street.

Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe.

By Will Ashworth, InvestorPlace Contributor Feb 19, 2024

Layoffs were a big theme in 2023. Unless the economy drastically picks up in 2024, they could happen this year in large numbers.

ChatGPT Stock Predictions: 3 Companies the AI Bot Thinks Have 10X Potential

By Faizan Farooque, InvestorPlace Contributor Feb 14, 2024

Navigate the stock market with confidence using AI stock predictions. Harness the latest in AI technology for strategic investment planning.

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 11, 2024

Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.

7 Stocks to Sell as Fast as You Possibly Can

By Louis Navellier and the InvestorPlace Research Staff Feb 8, 2024

Don't be nostalgic about these. Dumping each of these stocks to sell now will go a long way toward saving your portfolio.

3 Stocks Poised to Bounce Back After a Brutal 2023

By Joel Baglole, InvestorPlace Contributor Jan 18, 2024

These companies, which badly lagged the market last year, now look to be turning things around and could be rebound stocks in the year ahead.

7 Mighty Healthcare Stocks Changing the Game of Medicine

By Josh Enomoto, InvestorPlace Contributor Jan 17, 2024

With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily,…

7 Healthcare Stocks Taking Medicine to the Next Level

By Josh Enomoto, InvestorPlace Contributor Jan 14, 2024

While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio.…

3 Megatrend Stocks that Will Revolutionize Your Portfolio

By Matthew Farley, InvestorPlace Contributor Jan 11, 2024

Consider these powerhouse stocks for likely significant capital appreciation, growth, and rewards for your portfolio.

Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025

By Yiannis Zourmpanos, InvestorPlace Contributor Jan 9, 2024

Unveil three standout companies set to double investments by 2025 with groundbreaking strategies in tech and healthcare.

7 S&P 500 Stocks to Buy to Keep the Bull Market Running

By Rich Duprey, InvestorPlace Contributor Jan 9, 2024

The S&P 500 index is approaching a new all-time high and these seven stocks will keep the bull market running.

2 Major Reasons Why Moderna (MRNA) Stock Is Up Today

By Chris MacDonald, InvestorPlace Contributor Jan 2, 2024

One of the most beaten-down stocks of 2023 in the biotech space, Moderna is seeing a rebound today, with MRNA stock up 15%.

The Winners and Losers: 2023 Stock Market Performance Review

By Jeremy Flint, InvestorPlace Contributor Dec 27, 2023

The 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't).

Moderna Inc (MRNA)

3 Pharma Stocks to Sell in April Before They Crash & Burn

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Moderna Inc (MRNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and Moderna Inc News

Subscriber Sign in